November 2 (SeeNews) - Austria's Erste Bank said on Friday it maintained its "accumulate" stock recommendation on Romanian drug firm A&D Pharma and raised its target price for the company's Global Repository Receipts (GDRs) to 18.9 euro ($27.3), to reflect a rise in the company's half-year net profit and sales.